ClinicalTrials.gg
Drug

Fostamatinib clinical trials

Also written Tavalisse.

studies test it
54
open now
5
in phase 3
12
first study started
2006

How each study uses fostamatinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the fostamatinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Apr 2018 · TAVALISSE · NDA 209299 (FDA, Drugs@FDA)
European Union
9 Jan 2020 · Tavlesse · EMEA/H/C/005012 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fostamatinib
42
R788
10
R935788
10
Fostamatinib disodium
8
Fostamatinib disodium (R935788)
4

Brand

Tavalisse
3

Development codes

R-935788 Free Acid
1
R788 Free Acid
1

Studies by the year they started

54 studies that test it; most in 2011 (8)

Studies that test fostamatinib, by start year
YearStudies
20061
20072
20084
20092
20106
20118
20126
20143
20152
20162
20181
20194
20202
20214
20221
20231
20241
20252
20262

Who runs them

Industry 37 · Other 17

AstraZeneca (21) · Rigel Pharmaceuticals (15) · National Heart, Lung, and Blood Institute (NHLBI) (5) · Imperial College London (2) · Stefanie Sarantopoulos, MD, PhD. (2) · Kissei Pharmaceutical Co., Ltd. (1) · M.D. Anderson Cancer Center (1) · Sean Collins (1)

Often tested with

Tested in the same studies.

Ruxolitinib (2) · Talfirastide (1) · Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OH (1) · Simvastatin (1) · Pioglitazone (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test fostamatinib.

Studies

Open first, then newest update. How each study uses fostamatinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 54

See all 54 studies that test fostamatinib →

Given beside what is tested · 1 — fostamatinib is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with fostamatinib

Codes

What other systems call fostamatinib · ClinicalTrials.gg INT005170

  • MeSH (NLM) C523665fostamatinibOne source NLM
  • UNII (FDA) SQ8A3S5101FOSTAMATINIBConfirmed FDA, NLM, Wikidata
  • RxNorm 2044896One source FDA
  • Wikidata Q5473550fostamatinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C95222FostamatinibOne source FDA
  • DrugBank DB12010One source Wikidata

Also registered as fostamatinib disodium (UNII 86EEZ49YVB · RxNorm 2055929) and fostamatinib disodium anhydrous (UNII X9417132K8).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.